Rd. Spealman, NORADRENERGIC INVOLVEMENT IN THE DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE IN SQUIRREL-MONKEYS, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 53-62
Noradrenergic involvement in the discriminative stimulus (DS) effects
of cocaine was investigated in squirrel monkeys by using a two-lever d
rug discrimination procedure in which responding was maintained by a f
ixed-ratio schedule of stimulus-shock termination. Monkeys initially w
ere trained to discriminate a relatively high dose of cocaine (1.0 mg/
kg i.m.) from saline and subsequently were retrained to discriminate a
3.3- to 5.6-fold lower dose of cocaine (0.30 or 0.18 mg/kg i.m.). The
selective norepinephrine[fnc] uptake inhibitors talsupram, tomoxetine
, nisoxetine and desipramine substituted for cocaine in the majority o
f subjects under the low-dose training condition, whereas the selectiv
e dopamine uptake inhibitor GBR 12909 [1 henyl)methoxy]ethyl)-4-(3-phe
nylpropyl)piperazine] substituted for cocaine under both training cond
itions and the selective serotonin uptake inhibitor citalopram failed
to substitute for cocaine under either condition. Representative alpha
-1 [St 587 hloro-5-trifluoromethyl-phenylimino)imidazolidine) and SDZ
NVI 085 thyl-9-(methylthio)-2H-naphth[2,3-b]-1,(oxazine)], alpha-2 (cl
onidine and UK 14,304 (4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine
)) and beta (clenbuterol) adrenoceptor agonists did not consistently s
ubstitute for cocaine under either condition in which they were studie
d. Pretreatment with the alpha-1 adrenoceptor blocker prazosin antagon
ized the DS effects of cocaine under both training conditions as well
as the cocaine-like effects of talsupram and tomoxetine, but not GBR 1
2909, under the low-dose training condition. Pretreatment with the alp
ha-2 blocker efaroxan, the nonselective alpha blocker phentolamine and
the beta blocker propranolol failed to alter the DS effects of cocain
e consistently under either condition in which they were studied. Pret
reatment with talsupram, at doses that did not substitute for cocaine
when administered alone, enhanced the cocaine-like effects of GBR 1290
9 under both training conditions. The results support a role for norep
inephrine uptake and alpha-1 adrenoceptor mechanisms in the DS effects
of cocaine, possibly reflecting a facilitory noradrenergic influence
on mesocorticolimbic dopamine activity.